The SARS-CoV-2 pandemic is straining healthcare systems worldwide, and a global ventilator shortage is fueling the dire situation. As a response, the MIT E-Vent Team (S1) manufactured a scalable ventilator prototype for mass production and demonstrated basic clinical feasibility.

MIT E-Vent engineering information and capabilities, but also missing safety features are provided on the MIT E-Vent website (<https://e-vent.mit.edu/>) and in the attachments (Fig. [1](#Fig1){ref-type="fig"}a, S2). Pressure-based alarms were implemented including in the \`Spiro Wave' device that is based on the MIT E-vent and was just authorized for emergency use by the US FDA. In brief, the MIT E-Vent houses a manual resuscitator, an external compression mechanism, and a control system for adjusting tidal volumes, inspiration-to-expiration ratio, and respiratory rate (Fig. [1](#Fig1){ref-type="fig"}a, S3, S4). The MIT E-Vent is equipped with a pressure relief and a positive end-expiratory pressure (PEEP) valve. It delivers unassisted (Fig. [1](#Fig1){ref-type="fig"}b) and assisted (not shown) volume control ventilation (VCV). As a proof of concept, a pig was ventilated with the MIT E-Vent or a standard mechanical ventilator (SMV) at distinct settings and arterial blood gases, ventilator waveforms, and flow-volume loops were obtained.

The MIT E-Vent performed similar to a SMV at identical respiratory settings. After 36 h of usage including at high demand settings (TV 600 cc, RR 30, PEEP 20), no signs of device failure were noted (S5).

**Tidal volume delivery**

MIT E-Vent waveforms showed a smooth tidal volume delivery (Fig. [1](#Fig1){ref-type="fig"}b). It revealed similar flow-volume loops when compared to manual ventilation using a manual resuscitator (Fig. [1](#Fig1){ref-type="fig"}c).

**Gas exchange**

MIT E-Vent settings were changed to achieve 'low' and 'high' minute ventilation, and 'low' and 'high' FiO2 states as reflected in the ABGs (Fig. [1](#Fig1){ref-type="fig"}d, e).Fig. 1MIT E-Vent. Prototype design (**a**). Waveforms and flow-volume loops (**b** and **c**). Ventilation (**d**) and oxygenation testing (**e**)

The MIT E-Vent provides (un-)assisted VCV, variable MV, and PEEP with airway pressure profiles comparable to a SMV. The MIT E-Vent is not equipped to provide pressure control ventilation (PCV), which may make it unsuitable for awake and the most complex ARDS patients. However, this device is meant as a bridging tool when a conventional ventilator is not available, to serve as 'destination ventilator device' in the absence of any alternatives, or to help free up SMV in certain cases.

The MIT E-Vent Team was determined to equip the MIT E-Vent with comprehensive safety features including oxygen and flow sensors, but due to widespread hardware supply shortages, this became impossible. Omitting these safety features was deemed necessary to provide a rapidly scalable prototype. Consequently, increased clinical monitoring is required to provide adequate safety during the use of the MIT E-Vent (S2). Despite these limitations, the MIT-E Vent offers basic mechanical ventilation for selected patients during this ventilator shortage.

The MIT E-Vent Team invites the global community to improve and distribute a version of this scalable, low-cost ventilator during this COVID-19 pandemic.

Oxygenation and ventilation capabilities of a scalable, low-cost ventilator were demonstrated. MIT E-Vent engineering documentation was made public to rapidly implement the MIT E-Vent into the clinical care of patients requiring invasive mechanical ventilation.
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The MIT E-Vent Team group details are listed in the acknowledgement section.

**Publisher\'s Note**

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Albert H. Kwon and Alexander H. Slocum Jr they have contributed equally to this work.

**MIT E-Vent Engineering**: Brandon Araki -- PhD Candidate, Computer Science and Artificial Intelligence Laboratory (CSAIL), MIT Murad Abu-Kalaf, PhD -- Research Scientist, Computer Science and Artificial Intelligence Laboratory (CSAIL), MIT Mike Detienne, BS -- MIT Alum (Electrical Engineering) David Hagan, PhD -- CEO, QuantAQ; MIT Alum, (Atmospheric Physics & Chemistry) Nevan Hanumara, PhD -- Research Scientist, Mechanical Engineering, MIT (Alum) Kimberly Jung, MS, MBA -- MIT Alum (Mechanical Engineering) Teddy Ort -- PhD Candidate, Computer Science and Artificial Intelligence Laboratory (CSAIL), MIT Aaron Ramirez -- PhD Candidate, Mechanical Engineering, MIT Folkers Rojas, PhD -- Founder, Raptor Designs; MIT Alum (Mechanical Engineering) Daniela Rus, PhD -- Director, Computer Science and Artificial Intelligence Laboratory (CSAIL), MIT Amelia Servi, PhD -- R&D Engineer, Creare, LLC; MIT Alum (Mechanical Engineering) Shakti Shaligram, MS -- Research Scientist, IDM; MIT Alum (Integrated Design and Management) Alexander Slocum, PhD -- Professor of Mechanical Engineering, MIT Jonathan Slocum, ScD -- MIT Alum (Mechanical Engineering) Alexander Slocum, Jr, MD PhD -- Department of Plastic & Reconstructive Surgery, Medical College of Wisconsin; MIT Alum (Mechanical Engineering) Coby Unger, BS; MIT Hobby Shop. **MIT E-Vent Clinical Team:** Jay Connor, MD -- Orthopaedic Surgery, Mt Auburn Hospital Bon Ku, MD -- Assistant Dean for Medical Education and Associate Professor of Emergency Medicine, Thomas Jefferson University, Sidney Kimmel Medical College Albert Kwon, MD -- Assistant Professor of Anesthesiology, Department of Anesthesiology, Westchester Medical Center, New York Medical College Christoph Nabzdyk, MD -- Assistant Professor of Anesthesiology, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester Alexander Slocum, Jr, MD PhD -- Department of Plastic & Reconstructive Surgery, Medical College of Wisconsin Dirk Varelmann, MD -- Assistant Professor of Anesthesiology, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School. **Clinical Advisors:** John Callahan, MD - Internal Medicine, St. Joseph's Hospital Health Center & Veterans Administration Hospital, Syracuse Sergey Karamnov, MD - Instructor of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School Keith G Lurie, MD -- Professor of Emergency Medicine, University of Minnesota Niels Olson, Lt Cmdr, MD -- Laboratory Medical Director, US Naval Hospital, Guam; Professor, Uniformed Services University Neil Ray, MD -- Anesthesiologist; Founder & CEO, Raydiant Oximetry Mark Rosen, MD -- Professor of Anesthesiology (Ret), University of California, San Francisco; CMO, Raydiant Oximetry Steven Shafer, MD -- Professor of Anesthesiology, Perioperative and Pain Medicine, Stanford University Scott Sparks, Lt Col, MD -- Anesthesiologist, US Naval Hospital, Guam. **Manuscript Composition and Editing Leena:** Pradhan-Nabzdyk, PhD, MBA - Assistant Professor of Surgery, Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School. **2010 2.75 Project Team:** Amelia Servi, PhD -- R&D Engineering, Creare, LLC Abdul Mohsen Al Husseini, PhD -- Co-Founder & Chief Strategy Officer, Analytical Space, Inc. Justin Negrete, MS -- Thermal Engineer, Ford Motor Company, Inc. Stephen Powelson, BS -- Senior Mechanical Engineer, Rani Therapeutics, LLC Heon Ju Lee, PhD - Executive Director, Kyperion Co. Ltd.

On behalf of all authors, the corresponding author states that there is no conflict of interest.
